Military pharmacist appointed to APhA
WASHINGTON — The American Pharmacists Association has appointed Stacia Spridgen as director of its federal pharmacy program, the group said Wednesday.
The APhA said Spridgen, a retired Army lieutenant colonel, would be responsible for all aspects of the APhA’s federal pharmacy programs, including coordination of the annual Federal Forum and oversight management of the Department of Defense Joint Forces Pharmacy Seminar, fostering a collaborative alliance between the APhA and the federal pharmacy sector and developing relationships in the pharmaceutical industry.
Spridgen most recently served as director of the Department of Defense Pharmacoeconomic Center at Ft. Sam Houston, Texas, promoting cost-effective drug therapy throughout the Military Health System. Previously, she worked as executive officer for the Office of the Surgeon General and in other healthcare-related positions in the military.
"Stacia’s background in military and federal pharmacy programs is extensive and will be a great addition to the APhA federal pharmacy program," APhA EVP and CEO Thomas Menighan said. "Her years of service and experience with developing pharmacy programs, running clinics [and] advocating for policy that will help pharmacists produce high-quality services will build upon APhA’s long-standing programs."
Graine de Vie develops new (seed) grape-seed-enriched shaving bar
PRINCETON, N.J. — Graine de Vie has announced the launch of its new (seed) grape-seed-enriched shaving bar.
The 100%-natural shaving bar is made with grape seed oil and shea butter to seal in moisture and primrose seed oil for irritation-free shaving. It also has aloe to soothe and calm skin.
The bar is designed to lather into as much or little lather as you like, and is packaged in a recyclable carton made from at least 30% post-consumer paper.
The suggested retail price is $3.49.
NCPA identifies track-and-trace best practices
ALEXANDRIA, Va. — The National Community Pharmacists Association on Wednesday expressed its concerns over track-and-trace systems in its comments submitted to the U.S. Senate Health, Education, Labor and Pensions Committee hearing, “Securing the Pharmaceutical Supply Chain.”
"NCPA continues to feel that track-and-trace technologies remain largely unproven and such a system may prove to be prohibitively expensive for independent community pharmacies," stated Douglas Hoey, NCPA EVP and CEO. "We have identified a number of essential elements that should be considered as any proposed track and trace system is developed."
The NCPA had the following recommendations for the federal government:
- Any track-and-trace system should have a risk-based approach to determine the scope of which products will be targeted at the outset of the program, such as controlled substances and frequently counterfeited products;
- Federal grants designed to incentivize adapting of any track-and-trace program should include smaller participants in the supply chain, such as independent community pharmacies, that otherwise would be unduly financially burdened;
- There should be interoperability between the various systems for any track-and-trace program to pave the way for easier communications between various manufacturers and distributors;
- An authentication consensus should emerge about the definition and timing of when products will be verified, along with what will happen should the verification standard not be meet at any step in the process; and
- Independent community pharmacists should be allowed to use inference — a process that would allow them to scan or verify prescription drugs in larger batches instead of bottle by bottle.
“NCPA believes that the U.S. pharmaceutical supply chain is safe and secure,” Hoey said. “There are a number of different tactics or approaches that could provide further assurances of integrity — including efforts to combat pharmaceutical cargo theft and the implementation of national, uniform federal license standards for drug wholesalers.”